Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

The effects of comorbid Tourette symptoms on distress caused by compulsive-like behavior in very young children: a cross-sectional study.

Goto R, Fujio M, Matsuda N, Fujiwara M, Nobuyoshi M, Nonaka M, Kono T, Kojima M, Skokauskas N, Kano Y.

Child Adolesc Psychiatry Ment Health. 2019 Jun 28;13:28. doi: 10.1186/s13034-019-0290-3. eCollection 2019.

2.

Effect of QRS Morphology and Duration on Clinical Outcomes After Cardiac Resynchronization Therapy - Analysis of Japanese Multicenter Registry.

Oka T, Inoue K, Tanaka K, Hirao Y, Isshiki T, Kimura T, Nobuyoshi M, Shizuta S, Arita T, Fujii S, Iwakura K, Fujii K, Ando K.

Circ J. 2018 Jun 25;82(7):1813-1821. doi: 10.1253/circj.CJ-17-1383. Epub 2018 Apr 7.

3.

Duration of reverse remodeling response to cardiac resynchronization therapy: Rates, predictors, and clinical outcomes.

Oka T, Inoue K, Tanaka K, Toyoshima Y, Isshiki T, Kimura T, Nobuyoshi M, Shizuta S, Arita T, Fujii S, Iwakura K, Fujii K, Ando K.

Int J Cardiol. 2017 Sep 15;243:340-346. doi: 10.1016/j.ijcard.2017.05.058. Epub 2017 May 12.

PMID:
28545852
4.

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis.

Abdelmegid MA, Ahmed TA, Kato M, Ando K, Domei T, Iwabuchi M, Nobuyoshi M.

J Saudi Heart Assoc. 2017 Apr;29(2):76-83. doi: 10.1016/j.jsha.2016.10.001. Epub 2016 Oct 14.

5.

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria.

An Y, Ando K, Soga Y, Nomura A, Nagashima M, Hayashi K, Makihara Y, Fukunaga M, Hiroshima KI, Nobuyoshi M, Goya M.

J Arrhythm. 2017 Feb;33(1):17-22. doi: 10.1016/j.joa.2016.01.012. Epub 2016 Jun 28.

6.

Multiple somatic symptoms and frailty: cross-sectional study in Japanese community-dwelling elderly people.

Yamanashi H, Shimizu Y, Koyamatsu J, Nobuyoshi M, Nagayoshi M, Kadota K, Tamai M, Maeda T.

Fam Pract. 2016 Oct;33(5):453-60. doi: 10.1093/fampra/cmw028. Epub 2016 Apr 29.

PMID:
27130337
7.

Association between adult short stature and cerebral microbleeds.

Yamanashi H, Shimizu Y, Nagaoki K, Murase K, Koyamatsu J, Nobuyoshi M, Nagayoshi M, Kadota K, Tamai M, Tateishi Y, Tsujino A, Maeda T.

Int J Stroke. 2016 Feb;11(2):NP27-9. doi: 10.1177/1747493015620810. No abstract available.

PMID:
26783321
8.

Exercise-Induced Pulmonary Edema in a Triathlon.

Yamanashi H, Koyamatsu J, Nobuyoshi M, Murase K, Maeda T.

Case Rep Med. 2015;2015:968152. doi: 10.1155/2015/968152. Epub 2015 Jul 2.

9.

Antiplatelet therapy discontinuation and stent thrombosis after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.

Yano M, Natsuaki M, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitsudo K, Kimura T; j-Cypher Registry Investigators.

Int J Cardiol. 2015 Nov 15;199:296-301. doi: 10.1016/j.ijcard.2015.06.023. Epub 2015 Jun 18.

PMID:
26226333
10.

Clinical efficacy of thrombus aspiration on 5-year clinical outcomes in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention.

Watanabe H, Shiomi H, Nakatsuma K, Morimoto T, Taniguchi T, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO‐Kyoto AMI investigators, Kimura T, Sakata R, Marui A, Matsuda M, Mitsuoka H, Onoe M, Nakagawa Y, Yamanaka K, Fujiwara H, Takatsu Y, Ohno N, Nohara R, Murakami T, Takeda T, Nobuyoshi M, Iwabuchi M, Hanyu M, Tatami R, Matsushita T, Shirotani M, Nishiwaki N, Kita T, Furukawa Y, Okada Y, Kato H, Eizawa H, Is K, Tanaka M, Nakayama S, Lee JD, Nakano A, Koshiji T, Morioka K, Takizawa A, Shimamoto M, Yamazaki F, Takahashi M, Nishizawa J, Horie M, Takashima H, Tamura T, Aota M, Takahashi M, Tabata T, Tei C, Hamasaki S, Imoto Y, Yamamoto H, Kambara H, Doi O, Matsuda K, Nara M, Mitsudo K, Kadota K, Komiya T, Miki S, Mizoguchi T, Nakajima H, Ogawa H, Sugiyama S, Kawasuji M, Moriyama S, Hattori R, Aoyama T, Araki M, Suwa S, Tanbara K, Kitagawa K, Yamauchi M, Okamoto N, Fujino Y, Tezuka S, Saeki A, Hanazawa M, Sato Y, Hibi C, Sasae H, Takinami E, Uchida Y, Yamamoto Y, Nishida S, Yoshimoto M, Maeda S, Miki I, Minematsu S, Abe M, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Tokushige A, Natsuaki M, Nakajima T.

J Am Heart Assoc. 2015 Jun 15;4(6):e001962. doi: 10.1161/JAHA.115.001962. Erratum in: J Am Heart Assoc. 2015 Nov;4(11). pii: e001945. doi: 10.1161/JAHA.115.001945.

11.

Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2.

Watanabe H, Morimoto T, Natsuaki M, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kastrati A, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.

PLoS One. 2015 Apr 8;10(4):e0124314. doi: 10.1371/journal.pone.0124314. eCollection 2015.

12.

Vascular response after Zilver PTX stent implantation for superficial femoral artery lesions: serial optical coherence tomography findings at 6 and 12 months.

Tomoi Y, Kuramitsu S, Soga Y, Aihara H, Ando K, Nobuyoshi M.

J Endovasc Ther. 2015 Feb;22(1):41-7. doi: 10.1177/1526602814566577.

PMID:
25775679
13.

Impact of the bifurcation angle on major cardiac events after cross-over single stent strategy in unprotected left main bifurcation lesions: 3-dimensional quantitative coronary angiographic analysis.

Amemiya K, Domei T, Iwabuchi M, Shirai S, Ando K, Goya M, Yokoi H, Nobuyoshi M.

Am J Cardiovasc Dis. 2014 Dec 29;4(4):168-76. eCollection 2014.

14.

Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis.

Yamaji K, Kubo S, Inoue K, Kadota K, Kuramitsu S, Shirai S, Ando K, Nobuyoshi M, Mitsudo K, Kimura T.

PLoS One. 2014 Nov 25;9(11):e113870. doi: 10.1371/journal.pone.0113870. eCollection 2014.

15.

Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: five-year follow-up optical coherence tomography study.

Kuramitsu S, Sonoda S, Yokoi H, Iwabuchi M, Nishizaki Y, Shinozaki T, Domei T, Hyodo M, Inoue K, Shirai S, Ando K, Nobuyoshi M.

Atherosclerosis. 2014 Nov;237(1):23-9. doi: 10.1016/j.atherosclerosis.2014.08.031. Epub 2014 Aug 20.

PMID:
25190308
16.

Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.

Nakahashi T, Arita T, Yamaji K, Inoue K, Yokota T, Hoshii Y, Fukunaga M, Nomura A, Watanabe H, Miura S, Isotani A, Soga Y, Ando K, Iwabuchi M, Yokoi H, Nosaka H, Yamagishi M, Nobuyoshi M.

Int J Cardiol. 2014 Oct 20;176(3):753-9. doi: 10.1016/j.ijcard.2014.07.100. Epub 2014 Aug 2.

PMID:
25131905
17.

Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.

Tokushige A, Shiomi H, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Ohishi M, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Imoto Y, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Circ Cardiovasc Interv. 2014 Aug;7(4):482-91. doi: 10.1161/CIRCINTERVENTIONS.113.001056. Epub 2014 Jul 29.

PMID:
25074253
18.

Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Goto K, Nakai K, Shizuta S, Morimoto T, Shiomi H, Natsuaki M, Yahata M, Ota C, Ono K, Makiyama T, Nakagawa Y, Furukawa Y, Kadota K, Takatsu Y, Tamura T, Takizawa A, Inada T, Doi O, Nohara R, Matsuda M, Takeda T, Kato M, Shirotani M, Eizawa H, Ishii K, Lee JD, Takahashi M, Horie M, Takahashi M, Miki S, Aoyama T, Suwa S, Hamasaki S, Ogawa H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto Registry Cohort-2 Investigators.

Am J Cardiol. 2014 Jul 1;114(1):70-8. doi: 10.1016/j.amjcard.2014.03.060. Epub 2014 Apr 24.

19.

Incidence and clinical impact of stent fracture after the Nobori biolimus-eluting stent implantation.

Kuramitsu S, Iwabuchi M, Yokoi H, Domei T, Sonoda S, Hiromasa T, Morinaga T, Kobayashi Y, Ohe K, Goya K, Yamaji K, Hyodo M, Soga Y, Kondo K, Shirai S, Ando K, Sakai K, Nobuyoshi M.

J Am Heart Assoc. 2014 Mar 20;3(2):e000703. doi: 10.1161/JAHA.113.000703.

20.

A comparison of bolus injection of landiolol versus oral administration of propranolol before cardiac computed tomography.

Nakamura Y, Yamaji K, Saho T, Matsuzaki Z, Yuda I, Soga Y, Shirai S, Ando K, Nobuyoshi M.

Springerplus. 2014 Feb 17;3:93. doi: 10.1186/2193-1801-3-93. eCollection 2014.

21.

Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2.

Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.

Circ Cardiovasc Interv. 2014 Apr;7(2):168-79. doi: 10.1161/CIRCINTERVENTIONS.113.000987. Epub 2014 Feb 18.

PMID:
24550439
22.

The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases.

Kikuchi J, Yamada S, Koyama D, Wada T, Nobuyoshi M, Izumi T, Akutsu M, Kano Y, Furukawa Y.

J Biol Chem. 2013 Aug 30;288(35):25593-602. doi: 10.1074/jbc.M113.480574. Epub 2013 Jul 22.

23.

Percutaneous coronary intervention in patients with previous coronary artery bypass grafting (from the j-Cypher Registry).

Yamaji K, Kimura T, Morimoto T, Nakagawa Y, Inoue K, Nobuyoshi M, Mitsudo K; j-Cypher Registry Investigators.

Am J Cardiol. 2013 Oct 15;112(8):1110-9. doi: 10.1016/j.amjcard.2013.05.056. Epub 2013 Jul 2.

PMID:
23827399
24.

Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia.

Tomoi Y, Soga Y, Iida O, Hirano K, Suzuki K, Kawasaki D, Yamauchi Y, Miyashita Y, Tazaki J, Nobuyoshi M.

Cardiovasc Interv Ther. 2013 Oct;28(4):374-82. doi: 10.1007/s12928-013-0188-6. Epub 2013 Jun 12.

PMID:
23756936
25.

Long-term outcomes after percutaneous coronary intervention for chronic total occlusion (from the CREDO-Kyoto registry cohort-2).

Yamamoto E, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Ono K, Mitsudo K, Nobuyoshi M, Doi O, Tamura T, Tanaka M, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Am J Cardiol. 2013 Sep 15;112(6):767-74. doi: 10.1016/j.amjcard.2013.05.004. Epub 2013 Jun 1.

26.

Impact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention.

Kuramitsu S, Yokoi H, Domei T, Nomura A, Watanabe H, Yamaji K, Soga Y, Arita T, Kondo K, Shirai S, Ando K, Sakai K, Iwabuchi M, Nosaka H, Nobuyoshi M.

Cardiovasc Diabetol. 2013 May 7;12:74. doi: 10.1186/1475-2840-12-74.

27.

Homopiperazine derivatives as a novel class of proteasome inhibitors with a unique mode of proteasome binding.

Kikuchi J, Shibayama N, Yamada S, Wada T, Nobuyoshi M, Izumi T, Akutsu M, Kano Y, Sugiyama K, Ohki M, Park SY, Furukawa Y.

PLoS One. 2013 Apr 11;8(4):e60649. doi: 10.1371/journal.pone.0060649. Print 2013.

28.

Response to letter regarding article, "incidence and clinical impact of stent fracture after everolimus-eluting stent implantation".

Kuramitsu S, Iwabuchi M, Domei T, Hyodo M, Yamaji K, Soga Y, Arita T, Shirai S, Kondo K, Ando K, Sakai K, Goya M, Yokoi H, Nosaka H, Nobuyoshi M, Haraguchi T, Nagae A, Takabatake Y, Toyota F, Sonoda S.

Circ Cardiovasc Interv. 2013 Feb;6(1):e10. doi: 10.1161/CIRCINTERVENTIONS.112.976068. No abstract available.

PMID:
23424273
29.

Very long-term (15 to 23 years) outcomes of successful balloon angioplasty compared with bare metal coronary stenting.

Yamaji K, Kimura T, Morimoto T, Nakagawa Y, Inoue K, Kuramitsu S, Soga Y, Arita T, Shirai S, Ando K, Kondo K, Sakai K, Iwabuchi M, Yokoi H, Nosaka H, Nobuyoshi M.

J Am Heart Assoc. 2012 Oct;1(5):e004085. doi: 10.1161/JAHA.112.004085. Epub 2012 Oct 25.

30.

β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction.

Bao B, Ozasa N, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Natsuaki M, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T.

Cardiovasc Interv Ther. 2013 Apr;28(2):139-47. doi: 10.1007/s12928-012-0137-9. Epub 2012 Oct 11.

PMID:
23054967
31.

Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention.

Miura T, Soga Y, Doijiri T, Aihara H, Yokoi H, Iwabuchi M, Nobuyoshi M.

Circ J. 2013;77(1):89-95. Epub 2012 Sep 26.

32.

Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation: a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2.

Tokushige A, Shiomi H, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Tei C, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T.

Cardiovasc Interv Ther. 2013 Jan;28(1):45-55. doi: 10.1007/s12928-012-0136-x. Epub 2012 Sep 27.

PMID:
23015155
33.

Very long-term outcomes after percutaneous coronary intervention with bare metal stents for unprotected left main coronary artery disease.

Nomura A, Yamaji K, Shirai S, Omata F, Soga Y, Nagashima M, Arita T, Ando K, Sakai K, Goya M, Yokoi H, Iwabuchi M, Nobuyoshi M.

EuroIntervention. 2012 Dec 20;8(8):962-9. doi: 10.4244/EIJV8I8A146.

34.

Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation.

Kuramitsu S, Iwabuchi M, Haraguchi T, Domei T, Nagae A, Hyodo M, Yamaji K, Soga Y, Arita T, Shirai S, Kondo K, Ando K, Sakai K, Goya M, Takabatake Y, Sonoda S, Yokoi H, Toyota F, Nosaka H, Nobuyoshi M.

Circ Cardiovasc Interv. 2012 Oct;5(5):663-71. doi: 10.1161/CIRCINTERVENTIONS.112.969238. Epub 2012 Sep 25.

PMID:
23011266
35.

Iatrogenic peroneal artery pseudoaneurysm treated by transluminal coil embolization.

Miura T, Soga Y, Nobuyoshi M.

Cardiovasc Interv Ther. 2013 Jan;28(1):128-30. doi: 10.1007/s12928-012-0129-9. Epub 2012 Sep 18.

PMID:
22986765
36.

Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).

Shiomi H, Morimoto T, Hayano M, Furukawa Y, Nakagawa Y, Tazaki J, Imai M, Yamaji K, Tada T, Natsuaki M, Saijo S, Funakoshi S, Nagao K, Hanazawa K, Ehara N, Kadota K, Iwabuchi M, Shizuta S, Abe M, Sakata R, Okabayashi H, Hanyu M, Yamazaki F, Shimamoto M, Nishiwaki N, Imoto Y, Komiya T, Horie M, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Am J Cardiol. 2012 Oct 1;110(7):924-32. doi: 10.1016/j.amjcard.2012.05.022. Epub 2012 Jun 19.

37.

Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry.

Kimura T, Morimoto T, Nakagawa Y, Kadota K, Nozaki Y, Tada T, Take S, Shirota K, Ito A, Nakashima H, Fujita H, Kawasaki T, Inada T, Nakao K, Miyazaki S, Doi O, Isshiki T, Nobuyoshi M, Mitsudo K.

Cardiovasc Interv Ther. 2012 Sep;27(3):181-8. Epub 2012 Jun 14. Erratum in: Cardiovasc Interv Ther. 2013 Jan;28(1):135-6. Mitudo, Kazuaki [corrected to Mitsudo, Kazuaki].

PMID:
22695921
38.

The long-term efficacy of cilostazol in addition to dual antiplatelet therapy after sirolimus-eluting stent implantation for Japanese patients: an analysis of the 3-year follow-up outcomes from the j-Cypher registry.

Nakao T, Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Nobuyoshi M, Kita T, Mitsudo K.

Cardiovasc Interv Ther. 2012 Sep;27(3):161-7. Epub 2012 May 26.

PMID:
22638734
39.

Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2.

Tada T, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Byrne RA, Kastrati A, Kadota K, Iwabuchi M, Shizuta S, Tazaki J, Shiomi H, Abe M, Ehara N, Mizoguchi T, Mitsuoka H, Inada T, Araki M, Kaburagi S, Taniguchi R, Eizawa H, Nakano A, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Circ Cardiovasc Interv. 2012 Jun;5(3):381-91. doi: 10.1161/CIRCINTERVENTIONS.111.967463. Epub 2012 May 22.

PMID:
22619260
40.

[Indication for percutaneous coronary intervention].

Nobuyoshi M, Sakai K, Yamaji K.

Nihon Rinsho. 2011 Sep;69 Suppl 7:269-74. Review. Japanese. No abstract available.

PMID:
22519002
41.

Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2.

Tokushige A, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Ehara N, Inada T, Kaburagi S, Hamasaki S, Tei C, Nakashima H, Ogawa H, Tatami R, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.

Circ Cardiovasc Interv. 2012 Apr;5(2):237-46. doi: 10.1161/CIRCINTERVENTIONS.111.963728. Epub 2012 Mar 6.

PMID:
22396582
42.

Impact of statin therapy on late target lesion revascularization after sirolimus-eluting stent implantation (from the CREDO-Kyoto Registry Cohort-2).

Natsuaki M, Nakagawa Y, Morimoto T, Ono K, Shizuta S, Furukawa Y, Kadota K, Iwabuchi M, Kato Y, Suwa S, Inada T, Doi O, Takizawa A, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Am J Cardiol. 2012 May 15;109(10):1387-96. doi: 10.1016/j.amjcard.2012.01.350. Epub 2012 Feb 28.

PMID:
22381164
43.

Bare metal stent thrombosis and in-stent neoatherosclerosis.

Yamaji K, Inoue K, Nakahashi T, Noguchi M, Domei T, Hyodo M, Soga Y, Shirai S, Ando K, Kondo K, Sakai K, Iwabuchi M, Yokoi H, Nosaka H, Nobuyoshi M, Kimura T.

Circ Cardiovasc Interv. 2012 Feb 1;5(1):47-54. doi: 10.1161/CIRCINTERVENTIONS.111.964965. Epub 2012 Jan 17.

PMID:
22253359
44.

Primary percutaneous coronary intervention for acute myocardial infarction in the elderly aged ≥75 years.

Sakai K, Nagayama S, Ihara K, Ando K, Shirai S, Kondo K, Yokoi H, Iwabuchi M, Nosaka H, Nobuyoshi M.

Catheter Cardiovasc Interv. 2012 Jan 1;79(1):50-6. doi: 10.1002/ccd.22810. Epub 2011 Oct 5.

PMID:
22215567
45.

Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.

Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitudo K; j-Cypher Registry Investigators.

Circulation. 2012 Jan 31;125(4):584-91. doi: 10.1161/CIRCULATIONAHA.111.046599. Epub 2011 Dec 27.

PMID:
22203694
46.

Classification and clinical impact of restenosis after femoropopliteal stenting.

Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, Yokoi H, Nanto S, Nobuyoshi M.

J Am Coll Cardiol. 2012 Jan 3;59(1):16-23. doi: 10.1016/j.jacc.2011.09.036.

47.

Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention.

Domei T, Yokoi H, Kuramitsu S, Soga Y, Arita T, Ando K, Shirai S, Kondo K, Sakai K, Goya M, Iwabuchi M, Ueeda M, Nobuyoshi M.

Circ J. 2012;76(2):423-9. Epub 2011 Dec 8.

48.

Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis.

Iida O, Soga Y, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M, Muramatsu T, Inoue N, Nanto S, Uematsu M.

J Endovasc Ther. 2011 Dec;18(6):753-61. doi: 10.1583/11-3581.1.

PMID:
22149222
49.

Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study.

Shizuta S, Ando K, Nobuyoshi M, Ikeda T, Yoshino H, Hiramatsu S, Kazatani Y, Yamashiro K, Okajima K, Kajiya T, Kobayashi Y, Kato T, Fujii S, Mitsudo K, Inoue K, Ito H, Haruna Y, Doi T, Nishio Y, Ozasa N, Nishiyama K, Kita T, Morimoto T, Kimura T; PREVENT-SCD Investigators.

Clin Res Cardiol. 2012 Feb;101(2):89-99. doi: 10.1007/s00392-011-0368-2. Epub 2011 Sep 30.

50.

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery.

Soga Y, Iida O, Hirano K, Suzuki K, Tosaka A, Yokoi H, Nobuyoshi M.

J Vasc Surg. 2011 Oct;54(4):1058-66. doi: 10.1016/j.jvs.2011.03.286. Epub 2011 Aug 31.

Supplemental Content

Loading ...
Support Center